TLR2 and myeloid sarcoma: Activation of TLR2 signaling initiates a pro-inflammatory response and thereby drives the pathogenesis of neurodegeneration in a wide array of disorders ranging from infection-induced neuroinflammation to sterile neuroinflammation-associated conditions including stroke, MS, AD, PD and neuropathic pain [58, 59].